The AJMC® metabolic dysfunction-associated steatohepatitis compendium is a comprehensive resource for clinical news and expert insights for the condition, which was formerly known as nonalcoholic steatohepatitis.
Dietary Inflammatory Index Not Linked to Liver Fibrosis or Fatty Liver Index in MASLD
Surgeries and Endoscopic Procedures Offer Different Benefits for MASLD
Weight Loss Drug HU6 Shows Promise in MASH With Muscle-Sparing Benefits
Air Pollution, Obesity Linked to Significant Liver Fibrosis in Patients With MASH
Amplifying Impact: Efruxifermin Plus GLP-1RA Elevates MASH Outcomes